Julie E. Bauman, Lisa F. Licitra, Bhumsuk Keam, Jessica R. Bauman, Victor T. G. Lin, Neal Akhave, Jérôme Fayette, Prakash C. Neupane, Hussein Soudy, Byoung Chul Cho, Christine H. Chung, Nabil F. Saba, Deborah J.L. Wong, Kevin Joseph Harrington, Christophe Le Tourneau, Suzy Muggeo, Bo Jin, Claudia Lebedinsky, Edgar E. Braendle, Robert I. Haddad. "FIERCE-HN: A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of ficlatuzumab (HGF/cMET MAb) in combination with cetuximab in participants with recurrent or metastatic (R/M) HPV negative head and neck squamous cell carcinoma (HNSCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps6115